Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Epratuzumab inhibits the production of the proinflammatory cytokines IL-6 and TNF-α, but not the regulatory cytokine IL-10, by B cells from healthy donors and SLE patients.

Fleischer V, Sieber J, Fleischer SJ, Shock A, Heine G, Daridon C, Dörner T.

Arthritis Res Ther. 2015 Jul 17;17:185. doi: 10.1186/s13075-015-0686-2.

2.

Is preclinical autoimmunity benign?: The case of cardiovascular disease.

Majka DS, Chang RW.

Rheum Dis Clin North Am. 2014 Nov;40(4):659-68. doi: 10.1016/j.rdc.2014.07.006. Epub 2014 Sep 17. Review.

3.

Long-term B cell depletion in murine lupus eliminates autoantibody-secreting cells and is associated with alterations in the kidney plasma cell niche.

Wang W, Rangel-Moreno J, Owen T, Barnard J, Nevarez S, Ichikawa HT, Anolik JH.

J Immunol. 2014 Apr 1;192(7):3011-20. doi: 10.4049/jimmunol.1302003. Epub 2014 Feb 26.

4.

Carbon monoxide exposure improves immune function in lupus-prone mice.

Mackern-Oberti JP, Llanos C, Carreño LJ, Riquelme SA, Jacobelli SH, Anegon I, Kalergis AM.

Immunology. 2013 Sep;140(1):123-32. doi: 10.1111/imm.12124.

5.

Protein kinase cδ deficiency causes mendelian systemic lupus erythematosus with B cell-defective apoptosis and hyperproliferation.

Belot A, Kasher PR, Trotter EW, Foray AP, Debaud AL, Rice GI, Szynkiewicz M, Zabot MT, Rouvet I, Bhaskar SS, Daly SB, Dickerson JE, Mayer J, O'Sullivan J, Juillard L, Urquhart JE, Fawdar S, Marusiak AA, Stephenson N, Waszkowycz B, W Beresford M, Biesecker LG, C M Black G, René C, Eliaou JF, Fabien N, Ranchin B, Cochat P, Gaffney PM, Rozenberg F, Lebon P, Malcus C, Crow YJ, Brognard J, Bonnefoy N.

Arthritis Rheum. 2013 Aug;65(8):2161-71. doi: 10.1002/art.38008.

6.

The battle between infection and host immune responses of dengue virus and its implication in dengue disease pathogenesis.

Sun P, Kochel TJ.

ScientificWorldJournal. 2013;2013:843469. doi: 10.1155/2013/843469. Epub 2013 Feb 10. Review.

7.

Protein kinase Cβ is required for lupus development in Sle mice.

Oleksyn D, Pulvino M, Zhao J, Misra R, Vosoughi A, Jenks S, Tipton C, Lund F, Schwartz G, Goldman B, Mohan C, Mehta K, Mehta M, Leitgets M, Sanz I, Chen L.

Arthritis Rheum. 2013 Apr;65(4):1022-31. doi: 10.1002/art.37825.

8.

B-cell targeted therapy in systemic lupus erythematosus: potential of rituximab.

Wiesik-Szewczyk E, Olesinska M.

Biologics. 2012;6:347-54. doi: 10.2147/BTT.S25407. Epub 2012 Sep 26.

9.

Haem oxygenase 1 expression is altered in monocytes from patients with systemic lupus erythematosus.

Herrada AA, Llanos C, Mackern-Oberti JP, Carreño LJ, Henriquez C, Gómez RS, Gutierrez MA, Anegon I, Jacobelli SH, Kalergis AM.

Immunology. 2012 Aug;136(4):414-24. doi: 10.1111/j.1365-2567.2012.03598.x.

10.

Systemic lupus erythematosus presenting with eosinophilic enteritis: a case report.

Asadi Gharabaghi M, Abdollahi P, Kalany M, Sotoudeh M.

J Med Case Rep. 2011 Jun 25;5:235. doi: 10.1186/1752-1947-5-235.

11.

OX40/OX40L in systemic lupus erythematosus: association with disease activity and lupus nephritis.

Farres MN, Al-Zifzaf DS, Aly AA, Abd Raboh NM.

Ann Saudi Med. 2011 Jan-Feb;31(1):29-34. doi: 10.4103/0256-4947.75775.

12.

B cell immunology for the clinician.

Marcus C, Dhillon G, Anolik JH.

Pediatr Infect Dis J. 2011 Feb;30(2):158-60. doi: 10.1097/INF.0b013e318207447f. Review. No abstract available.

13.

Epratuzumab targeting of CD22 affects adhesion molecule expression and migration of B-cells in systemic lupus erythematosus.

Daridon C, Blassfeld D, Reiter K, Mei HE, Giesecke C, Goldenberg DM, Hansen A, Hostmann A, Frölich D, Dörner T.

Arthritis Res Ther. 2010;12(6):R204. doi: 10.1186/ar3179. Epub 2010 Nov 4.

14.

Prolonged effects of short-term anti-CD20 B cell depletion therapy in murine systemic lupus erythematosus.

Bekar KW, Owen T, Dunn R, Ichikawa T, Wang W, Wang R, Barnard J, Brady S, Nevarez S, Goldman BI, Kehry M, Anolik JH.

Arthritis Rheum. 2010 Aug;62(8):2443-57. doi: 10.1002/art.27515.

15.

Contribution of IRF5 in B cells to the development of murine SLE-like disease through its transcriptional control of the IgG2a locus.

Savitsky DA, Yanai H, Tamura T, Taniguchi T, Honda K.

Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10154-9. doi: 10.1073/pnas.1005599107. Epub 2010 May 17.

16.

Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity.

Watanabe R, Ishiura N, Nakashima H, Kuwano Y, Okochi H, Tamaki K, Sato S, Tedder TF, Fujimoto M.

J Immunol. 2010 May 1;184(9):4801-9. doi: 10.4049/jimmunol.0902385. Epub 2010 Apr 5.

17.

Disease activity in systemic lupus erythematosus is associated with an altered expression of low-affinity Fc gamma receptors and costimulatory molecules on dendritic cells.

Carreño LJ, Pacheco R, Gutierrez MA, Jacobelli S, Kalergis AM.

Immunology. 2009 Nov;128(3):334-41. doi: 10.1111/j.1365-2567.2009.03138.x.

18.

Autoantibody-dependent and autoantibody-independent roles for B cells in systemic lupus erythematosus: past, present, and future.

Jacob N, Stohl W.

Autoimmunity. 2010 Feb;43(1):84-97. doi: 10.3109/08916930903374600. Review.

19.

The role of B cells in lupus pathogenesis.

Nashi E, Wang Y, Diamond B.

Int J Biochem Cell Biol. 2010 Apr;42(4):543-50. doi: 10.1016/j.biocel.2009.10.011. Epub 2009 Oct 20. Review.

20.

A tolerogenic peptide down-regulates mature B cells in bone marrow of lupus-afflicted mice by inhibition of interleukin-7, leading to apoptosis.

Ben-David H, Sharabi A, Parameswaran R, Zinger H, Mozes E.

Immunology. 2009 Oct;128(2):245-52. doi: 10.1111/j.1365-2567.2009.03109.x.

Supplemental Content

Support Center